Mathematical modeling and analysis of export trends for certain pharmaceutical groups
Background. The analysis of the exports of medicines of the Russian Federation (RF) by group 30 (pharmaceutical products) of the commodity nomenclature of foreign economic activity of the Eurasian Economic Union (equal to Harmonized System Code 30, HS 30) is an important task for determining the eco...
Saved in:
| Main Authors: | , |
|---|---|
| Format: | Article |
| Language: | Russian |
| Published: |
IRBIS LLC
2024-08-01
|
| Series: | Фармакоэкономика |
| Subjects: | |
| Online Access: | https://www.pharmacoeconomics.ru/jour/article/view/1019 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1839584287127502848 |
|---|---|
| author | А. R. Shaikhislamova N. А. Gasratova |
| author_facet | А. R. Shaikhislamova N. А. Gasratova |
| author_sort | А. R. Shaikhislamova |
| collection | DOAJ |
| description | Background. The analysis of the exports of medicines of the Russian Federation (RF) by group 30 (pharmaceutical products) of the commodity nomenclature of foreign economic activity of the Eurasian Economic Union (equal to Harmonized System Code 30, HS 30) is an important task for determining the economic potential of the country in the pharmaceutical industry.Objective: building an export regression model. Development of an alternative mathematical model of pharmaceutical products’ export, suitable for making the forecast.Material and methods. Statistical data on HS 30 exports from 2010 to 2021 were taken from an open source: The International Trade Center (Trade Map). Data for 2022 and later for the Russian Federation are not available in open sources. Registration on the website is not required to collect statistics on export and import volumes based on annual data. The well-known statistical methods and methods of mathematical modeling were used. An alternative approach to regression analysis was developed. Technical data analysis was performed using MAPLE (Watcom Products Inc., Canada) and R (Bell Laboratories, USA) software.Results. Two models were constructed: Model I – a differential model based on cumulative data by year, and Model II – a model of standard regression analysis, the input parameters of which were quarterly export data, and the influencing parameters were a certain group of factors. Model I allowed considering the dynamics of changes in pharmaceutical exports over time (dynamic factors and nonlinear interactions). Model II, in turn, made it possible to determine the dependence of the volume of pharmaceutical exports on various economic indicators, such as gross domestic product, the volume of government procurement, and measures of protectionism. The relative error of Model I does not exceed 10%, which makes it suitable for forecasting.Conclusion. The construction and analysis of specified models help to provide main information about the trends in pharmaceutical product exports in the RF and assess its potential in the global market. The obtained results can be useful for developing strategies of the pharmaceutical industry development, making management decisions and forecasting future exports. |
| format | Article |
| id | doaj-art-03436364d2a74c20a85b7ce88971a714 |
| institution | Matheson Library |
| issn | 2070-4909 2070-4933 |
| language | Russian |
| publishDate | 2024-08-01 |
| publisher | IRBIS LLC |
| record_format | Article |
| series | Фармакоэкономика |
| spelling | doaj-art-03436364d2a74c20a85b7ce88971a7142025-08-03T19:49:37ZrusIRBIS LLCФармакоэкономика2070-49092070-49332024-08-0117215216210.17749/2070-4909/farmakoekonomika.2024.246490Mathematical modeling and analysis of export trends for certain pharmaceutical groupsА. R. Shaikhislamova0N. А. Gasratova1Saint Petersburg State UniversitySaint Petersburg State UniversityBackground. The analysis of the exports of medicines of the Russian Federation (RF) by group 30 (pharmaceutical products) of the commodity nomenclature of foreign economic activity of the Eurasian Economic Union (equal to Harmonized System Code 30, HS 30) is an important task for determining the economic potential of the country in the pharmaceutical industry.Objective: building an export regression model. Development of an alternative mathematical model of pharmaceutical products’ export, suitable for making the forecast.Material and methods. Statistical data on HS 30 exports from 2010 to 2021 were taken from an open source: The International Trade Center (Trade Map). Data for 2022 and later for the Russian Federation are not available in open sources. Registration on the website is not required to collect statistics on export and import volumes based on annual data. The well-known statistical methods and methods of mathematical modeling were used. An alternative approach to regression analysis was developed. Technical data analysis was performed using MAPLE (Watcom Products Inc., Canada) and R (Bell Laboratories, USA) software.Results. Two models were constructed: Model I – a differential model based on cumulative data by year, and Model II – a model of standard regression analysis, the input parameters of which were quarterly export data, and the influencing parameters were a certain group of factors. Model I allowed considering the dynamics of changes in pharmaceutical exports over time (dynamic factors and nonlinear interactions). Model II, in turn, made it possible to determine the dependence of the volume of pharmaceutical exports on various economic indicators, such as gross domestic product, the volume of government procurement, and measures of protectionism. The relative error of Model I does not exceed 10%, which makes it suitable for forecasting.Conclusion. The construction and analysis of specified models help to provide main information about the trends in pharmaceutical product exports in the RF and assess its potential in the global market. The obtained results can be useful for developing strategies of the pharmaceutical industry development, making management decisions and forecasting future exports.https://www.pharmacoeconomics.ru/jour/article/view/1019pharmaceutical marketcommercial sectorforeign trade turnovermathematical modelingsales dynamicshs 30mathematical model for imports and exports |
| spellingShingle | А. R. Shaikhislamova N. А. Gasratova Mathematical modeling and analysis of export trends for certain pharmaceutical groups Фармакоэкономика pharmaceutical market commercial sector foreign trade turnover mathematical modeling sales dynamics hs 30 mathematical model for imports and exports |
| title | Mathematical modeling and analysis of export trends for certain pharmaceutical groups |
| title_full | Mathematical modeling and analysis of export trends for certain pharmaceutical groups |
| title_fullStr | Mathematical modeling and analysis of export trends for certain pharmaceutical groups |
| title_full_unstemmed | Mathematical modeling and analysis of export trends for certain pharmaceutical groups |
| title_short | Mathematical modeling and analysis of export trends for certain pharmaceutical groups |
| title_sort | mathematical modeling and analysis of export trends for certain pharmaceutical groups |
| topic | pharmaceutical market commercial sector foreign trade turnover mathematical modeling sales dynamics hs 30 mathematical model for imports and exports |
| url | https://www.pharmacoeconomics.ru/jour/article/view/1019 |
| work_keys_str_mv | AT arshaikhislamova mathematicalmodelingandanalysisofexporttrendsforcertainpharmaceuticalgroups AT nagasratova mathematicalmodelingandanalysisofexporttrendsforcertainpharmaceuticalgroups |